Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
FEBS Letters
|
March 3, 1997
In vitro interaction of U2 snRNA with cytoplasmic 6S protein complexes
M G Fury, J Andersen
Experimental Cell Research
|
October 10, 1996
U6 snRNA maturation and stability
M G Fury, G W Zieve
Experimental Cell Research
|
January 7, 1998
Multiple protein: protein interactions between the snRNP common core proteins
M G Fury, W Zhang, I Christodoulopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2018
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
M G Fury, E J Sherman, S S Rao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
K D Lewis, K Peris, A Sekulic, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
FEBS Letters
|
March 3, 1997
In vitro interaction of U2 snRNA with cytoplasmic 6S protein complexes
M G Fury, J Andersen
Experimental Cell Research
|
October 10, 1996
U6 snRNA maturation and stability
M G Fury, G W Zieve
Experimental Cell Research
|
January 7, 1998
Multiple protein: protein interactions between the snRNP common core proteins
M G Fury, W Zhang, I Christodoulopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2018
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
L A Dunn, M G Fury, H Xiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
M G Fury, E J Sherman, S S Rao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
K D Lewis, K Peris, A Sekulic, et al.
Page
of 1